Artificial intelligence-based strategies to identify patient populations and advance analysis in age-related macular degeneration clinical trials.
Yaghy A, Lee AY, Keane PA, Keenan TDL, Mendonca LSM, Lee CS, Cairns AM, Carroll J, Chen H, Clark J, Cukras CA, de Sisternes L, Domalpally A, Durbin MK, Goetz KE, Grassmann F, Haines JL, Honda N, Hu ZJ, Mody C, Orozco LD, Owsley C, Poor S, Reisman C, Ribeiro R, Sadda SR, Sivaprasad S, Staurenghi G, Ting DS, Tumminia SJ, Zalunardo L, Waheed NK.
Yaghy A, et al. Among authors: durbin mk.
Exp Eye Res. 2022 Jul;220:109092. doi: 10.1016/j.exer.2022.109092. Epub 2022 May 4.
Exp Eye Res. 2022.
PMID: 35525297
Free PMC article.
No abstract available.